Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Affiliations

• ¹ Francis Crick Institute, London, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.
• ² Francis Crick Institute, London, UK.
• ³ University College London, London, UK.
• ⁴ Francis Crick Institute, London, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
• ⁵ National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.
• ⁶ Francis Crick Institute, London, UK; University College London, London, UK.
• ⁷ Francis Crick Institute, London, UK. Electronic address: david.bauer@crick.ac.uk.